The revitalization of thalidomide

被引：10

作者：

Thomas, DA ^{[1
]}

Kantarjian, HM ^{[1
]}

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

来源：

ANNALS OF ONCOLOGY | 2001年 / 12卷 / 07期

关键词：

D O I：

10.1023/A:1011123209816

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：885 / 886

页数：2

共 30 条

[1]

BARLOGIE B, 2000, P AN M AM SOC CLIN, V19, pA9

[2] Factors promoting tumor angiogenesis [J].

Beckner, ME .

CANCER INVESTIGATION, 1999, 17 (08) :594-623

[3] Thalidomide in multiple myeloma, myelodysplastic syndromes and histiocytosis. Analysis of clinical results and of surrogate angiogenesis markers [J].

Bertolini, F ;

Mingrone, W ;

Alietti, A ;

Ferrucci, PF ;

Cocorocchio, E ;

Peccatori, F ;

Cineri, S ;

Mancuso, P ;

Corsini, C ;

Burlini, A ;

Zucca, E ;

Martinelli, G .

ANNALS OF ONCOLOGY, 2001, 12 (07) :987-990

[4] Interaction of thalidomide, phthalimide analogues of thalidomide and pentoxifylline with the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid: concomitant reduction of serum tumour necrosis factor-alpha and enhancement of anti-tumour activity [J].

Ching, LM ;

Browne, WL ;

Tchernegovski, R ;

Gregory, T ;

Baguley, BC ;

Palmer, BD .

BRITISH JOURNAL OF CANCER, 1998, 78 (03) :336-343

[5] Immunomodulation by thalidomide and thalidomide analogues [J].

Corral, LG ;

Kaplan, G .

ANNALS OF THE RHEUMATIC DISEASES, 1999, 58 :107-113

[6] THALIDOMIDE IS AN INHIBITOR OF ANGIOGENESIS [J].

DAMATO, RJ ;

LOUGHNAN, MS ;

FLYNN, E ;

FOLKMAN, J .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) :4082-4085

[7]

DIMOPOULOS M, 2000, P AN M AM SOC CLIN, V19, pA27

[8] Thalidomide and dexamethasone combination for refractory multiple myeloma [J].

Dimopoulos, MA ;

Zervas, K ;

Kouvatseas, G ;

Galani, E ;

Grigoraki, V ;

Kiamouris, C ;

Vervessou, E ;

Samantas, E ;

Papadimitriou, C ;

Economou, O ;

Gika, D ;

Panayiotidis, P ;

Christakis, I ;

Anagnostopoulos, N .

ANNALS OF ONCOLOGY, 2001, 12 (07) :991-995

[9] Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset [J].

Haslett, PAJ ;

Corral, LG ;

Albert, M ;

Kaplan, G .

JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (11) :1885-1892

[10] Thalidomide increases both REM and stage 3-4 sleep in human adults: A preliminary study [J].

Kanbayashi, T ;

Shimizu, T ;

Takahashi, Y ;

Kitajima, T ;

Takahashi, K ;

Saito, Y ;

Hishikawa, Y .

SLEEP, 1999, 22 (01) :113-115

← 1 2 3 →